Progressive pulmonary fibrosis is not a diagnosis so much as a disease behavior and a clinical phenotype, says Anna-Maria ...

Pirfenidone use in patients with idiopathic pulmonary fibrosis may be linked to a lower incidence of lung cancer. Learn more.

They include a Kennewick vascular surgeon, a Tri-Cities Cancer Center radiation oncologist, family nurse practitioner in ...

Preoperative use of GLP-1 receptor agonists was not significantly associated with short-term postoperative aspiration ...

High-risk acute pulmonary embolism affects around 5% of all pulmonary embolisms and can take a dramatic course even in young ...

ICER assessed GSK's COPD inhalers, Trelegy Ellipta and Breo Ellipta, for Medicare price negotiations, highlighting their once-daily dosing and comparable net health benefits.

Does gabapentinoid use increase the risk of severe exacerbation in patients with chronic obstructive pulmonary disease (COPD) ...

A current study involving the University Hospital Bonn (UKB) has investigated which treatment strategy offers the best chances of survival in high-risk acute pulmonary embolism.

One study found that most people are at risk for developing DVT on one out of every 4,656 long flights, which is a relatively ...

Medically reviewed by Femi Aremu, PharmD Altitude sickness refers to symptoms of low oxygen, which may happen at elevations ...

The Institute for Clinical and Economic Review has prepared a special report on Trelegy and Breo, two therapies that treat ...